InVivoMAb anti-mouse PD-1 (CD279)
1/2

InVivoMAb anti-mouse PD-1 (CD279)

分享
品牌: BioXcell
pdf 下载产品说明书
pdf 下载SDS
用小程序,查商品更便捷
收藏
对比对比
咨询咨询
    反应种属:
    mouse
    mouse
    产品介绍
    产品信息
    克隆号
    29F.1A12
    克隆类别
    单抗

    Product Details

    The 29F.1A12™ monoclonal antibody reacts with mouse PD-1 (programmed death-1) also known as CD279. PD-1 is a 50-55 kDa cell surface receptor encoded by the Pdcd1 gene that belongs to the CD28 family of the Ig superfamily. PD-1 is transiently expressed on CD4 and CD8 thymocytes as well as activated T and B lymphocytes and myeloid cells. PD-1 expression declines after successful elimination of antigen. Additionally, Pdcd1 mRNA is expressed in developing B lymphocytes during the pro-B-cell stage. PD-1’s structure includes a ITIM (immunoreceptor tyrosine-based inhibitory motif) suggesting that PD-1 negatively regulates TCR signals. PD-1 signals via binding its two ligands, PD-L1 and PD-L2 both members of the B7 family. Upon ligand binding, PD-1 signaling inhibits T-cell activation, leading to reduced proliferation, cytokine production, and T-cell death. Additionally, PD-1 is known to play key roles in peripheral tolerance and prevention of autoimmune disease in mice as PD-1 knockout animals show dilated cardiomyopathy, splenomegaly, and loss of peripheral tolerance. Induced PD-L1 expression is common in many tumors including squamous cell carcinoma, colon adenocarcinoma, and breast adenocarcinoma. PD-L1 overexpression results in increased resistance of tumor cells to CD8 T cell mediated lysis. In mouse models of melanoma, tumor growth can be transiently arrested via treatment with antibodies which block the interaction between PD-L1 and its receptor PD-1. For these reasons anti-PD-1 mediated immunotherapies are currently being explored as cancer treatments. Like the RMP1-14 and J43 antibodies the 29F.1A12™ antibody has been shown to block the binding of PD-1 to its ligands in vivo.

    Specifications

    Isotype Rat IgG2a
    Recommended Isotype Control(s)InVivoMAb rat IgG2a isotype control, anti-trinitrophenol
    Recommended Dilution BufferInVivoPure pH 7.0 Dilution Buffer
    Conjugation This product is unconjugated. Conjugation is available via our Antibody Conjugation Services.
    Immunogen Recombinant PD-1-Ig fusion protein
    Reported Applicationsin vivo blocking of PD-1/PD-L signaling
    in vitro PD-1 neutralization
    Immunohistochemistry (frozen)
    Immunofluorescence
    Western blot
    Flow cytometry
    Formulation PBS, pH 7.0
    Contains no stabilizers or preservatives
    Endotoxin <2EU/mg (<0.002EU/μg)
    Determined by LAL gel clotting assay
    Purity >95%
    Determined by SDS-PAGE
    Sterility 0.2 µm filtration
    Production Purified from cell culture supernatant in an animal-free facility
    Purification Protein G
    RRIDAB_2687796
    Molecular Weight 150 kDa
    Storage The antibody solution should be stored at the stock concentration at 4°C. Do not freeze.
    组成成分
    抗鼠程序性死亡蛋白抗体,磷酸盐缓冲液
    应用
    反应种属
    mouse
    背景
    别名
    PD-1,PD1,CD279,hPD-1,PDCD1,Programmed cell death protein 1
    研究领域
    Cancer Biology, Immune Checkpoint Protein, Immunology
    声明 :本官网所有报价均为常温或者蓝冰运输价格,如有产品需要干冰运输,需另外加收干冰运输费。
    货号:
    BE0273-1MG
    一键复制
    询价
    1mg
    5mg
    25mg
    50mg
    100mg
    选择数量
    当前规格1件起购 
    配送至
    预计2-3周送达,快递: 免运费,若需干冰额外收费